Evidence map›Paper›PMID 35982468›Full record

ArticleTrials2022

Adaptive interventions to optimise the mobile phone-based smoking cessation support: study protocol for a sequential, multiple assignment, randomised trial (SMART).

Sheng Zhi Zhao, Xue Weng, Tzu Tsun Luk, Yongda Wu, Derek Yee Tak Cheung, William Ho Cheung Li, Henry Tong, Vienna Lai, Tai Hing Lam, Man Ping Wang

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03992742 (Building Capacity and Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2019), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03992742 naunknown statusnot on this map

Building Capacity and Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2019: Personalized Cocktail Interventions to Increase Abstinence: a Sequential, Multiple Assignment, Randomized Trial (SMART)

TypeinterventionalSponsorThe University of Hong KongRan2019 to 2021Enrolled1,200ConditionsSmoking CessationArmsInitial phase: personalized instant messaging (PIM), Second phase: optional cocktail interventions (OCI), Initial phase: regular instant messaging (RIM), Second phase: personalized instant messaging (PIM), AWARD advice
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Sheng Zhi Zhao *School of Nursing, The University of Hong Kong, Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong.
Xue Weng *School of Nursing, The University of Hong Kong, Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong. xueweng@bnu.edu.cn.
Tzu Tsun LukSchool of Nursing, The University of Hong Kong, Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong.
Yongda WuSchool of Nursing, The University of Hong Kong, Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong.
Derek Yee Tak CheungSchool of Nursing, The University of Hong Kong, Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong.
William Ho Cheung LiThe Nethersole School of Nursing, Chinese University of Hong Kong, Ma Liu Shui, Hong Kong.
Henry TongHong Kong Council on Smoking and Health, Wan Chai, Hong Kong.
Vienna LaiHong Kong Council on Smoking and Health, Wan Chai, Hong Kong.
Tai Hing LamSchool of Public Health, The University of Hong Kong, Pokfulam, Hong Kong.
Man Ping WangSchool of Nursing, The University of Hong Kong, Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong. mpwang@hku.hk.ORCID http://orcid.org/0000-0003-4000-2388
University of Hong Kong · HKHong Kong Council on Smoking and Health · CNBeijing Normal University · CNChinese University of Hong Kong · HK

Funding

Hong Kong Council on Smoking and Health HK$950,000
6 · The paper itself

Abstract

backgroundMobile health (mHealth) is promising in developing personalised smoking cessation interventions. By using an adaptive trial design, we aim to evaluate the effectiveness of personalised mHealth intervention in increasing smoking cessation.

methodsThis study is a two-arm, parallel, accessor-blinded Sequential Multiple-Assignment Randomised Trial (SMART) that randomises 1200 daily cigarette smokers from 70 community sites at two timepoints. In the first phase, participants receive brief cessation advice plus referral assistance to smoking cessation services and are randomly allocated to receive personalised instant messaging (PIM) or regular instant messaging (RIM). In the second phase, PIM participants who are non-responders (i.e. still smoking at 1 month) are randomised to receive either optional combined interventions (multi-media messages, nicotine replacement therapy sampling, financial incentive for active referral, phone counselling, and family/peer support group chat) or continued-PIM. Non-responders in the RIM group are randomised to receive PIM or continued-RIM. Participants who self-report quitting smoking for 7 days or longer at 1 month (responders) in both groups continue to receive the intervention assigned in phase 1. The primary outcomes are biochemical abstinence validated by exhaled carbon monoxide (< 4 ppm) and salivary cotinine (< 10 ng/ml) at 3 and 6 months from treatment initiation. Intention-to-treat analysis will be adopted. DISCUSSION: This is the first study using a SMART design to evaluate the effect of adaptive mHealth intervention on abstinence in community-recruited daily smokers. If found effective, the proposed intervention will inform the development of adaptive smoking cessation treatment and benefits smokers non-responding to low-intensity mHealth support.

trial registrationClinicalTrials.gov NCT03992742 . Registered on 20 June 2019.

Indexed as

Cell PhoneSmoking CessationText MessagingAdaptive Clinical Trials as TopicHumansRandomized Controlled Trials as TopicSmokersTobacco Use Cessation DevicesAdaptive trialInstant messagingmHealthSmoking cessationStepped care

Identifiers

PMID35982468
PMCPMC9387009
OpenAlexW4292478899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.